Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hib-DTP-hepatitis B vaccine - PT Bio Farma

X
Drug Profile

Hib-DTP-hepatitis B vaccine - PT Bio Farma

Alternative Names: Pentabio vaccine; Pentavalent vaccine - PT Bio Farma

Latest Information Update: 14 Aug 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PT Bio Farma
  • Class Bacterial vaccines; Conjugate vaccines; Haemophilus vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 01 Aug 2022 PT Bio Farma in collaboration with Hasan Sadikin General Hospital plans a phase III trial for Diphtheria, Haemophilus infections, Pertussis, Tetanus, Hepatitis B,(Prevention, In Infants) in Indonesia (IM, Injection) in October 2022 (NCT05482282)
  • 16 Dec 2021 PT Bio Farma completes a phase III trial for Diphtheria, Haemophilus infections, Hepatitis B, Pertussis, Tetanus (Prevention, In Infants) in Indonesia (IM) (NCT04071379)
  • 13 Oct 2020 PT Bio Farma initiates a phase III trial for Diphtheria, Haemophilus infections, Hepatitis B, Pertussis, Tetanus (Prevention, In Infants) in Indonesia (IM) (NCT04071379)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top